<code id='B63823933F'></code><style id='B63823933F'></style>
    • <acronym id='B63823933F'></acronym>
      <center id='B63823933F'><center id='B63823933F'><tfoot id='B63823933F'></tfoot></center><abbr id='B63823933F'><dir id='B63823933F'><tfoot id='B63823933F'></tfoot><noframes id='B63823933F'>

    • <optgroup id='B63823933F'><strike id='B63823933F'><sup id='B63823933F'></sup></strike><code id='B63823933F'></code></optgroup>
        1. <b id='B63823933F'><label id='B63823933F'><select id='B63823933F'><dt id='B63823933F'><span id='B63823933F'></span></dt></select></label></b><u id='B63823933F'></u>
          <i id='B63823933F'><strike id='B63823933F'><tt id='B63823933F'><pre id='B63823933F'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:8
          J.P. Morgan office building at night -- JPM health business coverage from STAT
          Adobe

          SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

          Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

          advertisement

          Their message? We’re still here. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          For Cytokinetics, FDA rejection of heart drug would help, not hinder

          MollyFerguson/STATCytokineticswasfounded26yearsagobuthasnotyetdevelopedadrugsuccessfullytoapproval.T